US allows increased production of Takeda’s ADHD drug to address shortage, ET HealthWorld
Bengaluru: The U.S. Drug Enforcement Administration (DEA) has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24 per cent to address the…